Laura Odemwingie

Pathway 0+3.5

Cohort 2021


I joined Kings after completing my MSci in Medical Biochemistry at the University of Bristol. My interest in neuroscience sparked when I completed a summer scholarship with the North Bristol NHS Trust Research Foundation on Biomarkers for Brain Tumours with Consultant Prof. Kathreena Kurian.

Throughout my time at Bristol I gravitated towards Neurobiochemistry and in particular neurodegeneration. Here, I went on to do my MSci project on synaptic plasticity and spine morphogenesis in Alzheimers disease with Dr Jonathan Hanley. As a result, I decided to remain within the area of neurodegeneration, and I choose the 0+3.5 route. I choose the MRC DTP because it gave me a wide catalogue of projects from which I could choose from, and also provides me the opportunity to become a well-rounded researcher by offering various seminars, workshops, and career opportunities. I also particularly enjoy the socialising and networking aspects within the wider MRC cohorts with my peers.

I am now working on investigating the molecular basis for selective vulnerability in FET-linked Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) with Dr Marc-David Ruepp and Dr Caroline Vance.

Social Media

Twitter: @LOdemwingie